Pharmacoeconomics consulting firms are experiencing growing demand in 2026 as payers, health technology assessment bodies, and pharmaceutical manufacturers place increasing weight on health economic and outcomes research (HEOR) evidence in coverage and reimbursement decisions. The Institute for Clinical and Economic Review (ICER) and international HTA bodies including NICE and G-BA are expanding their formal review processes for novel therapeutics, creating sustained need for pharmacoeconomic modeling, systematic literature reviews, and value dossier development. Managing the billing, client administration, and model coordination workflows that surround this expert analytical work is consuming capacity that health economists cannot afford to lose.
Virtual assistants are helping pharmacoeconomics consulting firms manage the operational infrastructure of their client relationships without diverting modeling and analysis expertise from the evidence work that drives client outcomes.
Billing Complexity in HEOR and Value Evidence Engagements
Pharmacoeconomics consulting billing reflects the complexity of the underlying work. Engagements span cost-effectiveness model development, budget impact analysis, indirect treatment comparison studies, patient-reported outcome surveys, and HTA dossier submissions — each with distinct deliverable structures and billing timelines. Managing milestone invoicing across multiple pharma and payer clients, tracking purchase order balances against contract scope, and coordinating billing documentation for multi-phase HEOR programs requires systematic administrative attention.
According to IQVIA's 2025 HEOR Outsourcing Report, the average pharmacoeconomic model development engagement spans 8 to 14 months from initiation to final delivery, involving multiple interim billing milestones and regular contract amendments as model scope evolves with incoming clinical data. Virtual assistants can manage milestone invoice preparation, track deliverable completion against contract terms, coordinate sponsor billing portal submissions, and follow up on payment schedules — ensuring billing cycles remain organized across long-duration HEOR programs.
Client Account Administration for Pharma and Payer Clients
Pharmacoeconomics consulting clients include pharmaceutical manufacturers, payer organizations, and government health agencies — each with distinct account administration requirements. Pharma manufacturer clients typically require engagement onboarding workflows involving therapeutic area briefings, modeling platform access configuration, and internal review team communication setup. Payer clients require HEOR summary distribution protocols and periodic outcomes data update schedules.
Virtual assistants can manage the onboarding and ongoing account administration for both client types. For pharma clients, they can coordinate the collection of clinical data packages, schedule model development kickoff meetings, distribute draft deliverables for client review, and track approval status across internal stakeholder teams. For payer clients, they can maintain distribution lists for HEOR summary reports, coordinate review meeting logistics, and organize evidence documentation archives.
McKinsey's 2024 Payer Strategy and Market Access report identified systematic evidence communication as a top driver of payer confidence in pharmacoeconomic data — a standard that requires organized, consistent administrative support.
HEOR Model Administration and HTA Coordination
HEOR model administration — managing version control for complex Excel or R-based cost-effectiveness models, distributing model review packages to client technical teams, tracking review comments and model revision requests, and coordinating quality control validation documentation — is a high-frequency administrative workflow embedded in every pharmacoeconomics consulting engagement. Virtual assistants can manage document distribution, review tracking, and model version organization without technical modeling expertise.
HTA coordination adds another layer. Submissions to ICER, NICE, G-BA, or other HTA bodies involve structured submission packages, strict submission deadlines, and formal response periods. Managing the logistics of HTA submissions — organizing submission documentation, tracking deadline calendars, distributing agency responses to client teams, and coordinating response preparation workflows — is administrative work with high stakes attached.
Deloitte's 2025 Market Access and HEOR Operations Report found that pharmacoeconomics consulting firms with structured HTA coordination support submitted to major HTA bodies an average of 11 days earlier than those relying on ad hoc coordination — reducing the risk of late submission penalties and missed evidence windows.
Building Scalable HEOR Operations
Pharmacoeconomics consulting firms competing for pharma and payer client relationships in 2026 need to demonstrate both analytical depth and operational reliability. Virtual assistants provide the administrative infrastructure — billing management, client communication, model coordination, HTA logistics — that makes operational reliability visible and sustainable as client portfolios grow.
Pharmacoeconomics consulting firms ready to reduce billing overhead, systematize HEOR model administration, and improve HTA coordination should explore what Stealth Agents can deliver.
Sources
- IQVIA, HEOR Outsourcing Report, 2025
- McKinsey & Company, Payer Strategy and Market Access, 2024
- Deloitte, Market Access and HEOR Operations Report, 2025